Table 2.
Correlations between steroid receptor RNA activator 1 expression and clinical characteristics in esophageal squamous cell carcinoma patients
| Characteristics | Case (n = 38) |
SRA1 expression
|
χ 2 | P value | |
|
High
|
Low
|
||||
| Sex | |||||
| Male | 26 | 12 | 14 | 0.487 | 0.485 |
| Female | 12 | 7 | 5 | ||
| Age (years) | 1.310 | 0.252 | |||
| ≤ 60 | 9 | 3 | 6 | ||
| > 60 | 29 | 16 | 13 | ||
| Pathological differentiation grade | 0.186 | 0.911 | |||
| Well | 7 | 4 | 3 | ||
| Moderately | 23 | 11 | 12 | ||
| Poorly | 8 | 4 | 4 | ||
| T Stage | 5.265 | 0.022a | |||
| T1-T2 | 20 | 13 | 7 | ||
| T3-T4 | 18 | 5 | 13 | ||
| TNM Stage | 8.622 | 0.003b | |||
| I-II | 17 | 13 | 4 | ||
| III-IV | 21 | 6 | 15 | ||
| Lymph node metastasis | 8.526 | 0.004b | |||
| Negative | 19 | 14 | 5 | ||
| Positive | 19 | 5 | 14 | ||
a
P < 0.05.
b
P < 0.01.
The χ2 test was used for comparison between groups. SRA1: Steroid receptor RNA activator 1.